Cryoport’s validated cryogenic logistics solution is supporting ZenBio Inc. in the distribution of its Human Platelet Lysate as well as its entire array of cell-based solutions for the discovery and development of regenerative therapies.

ZenBio offers its research partners a unique ‘cells and services’ model delivering robust cell-based solutions to accelerate the discovery and development of therapies to better the human condition.

There are different human blood components, cell tissues, and other products that support varying clinical development programmes.

The current initiative includes Human Serum to replace Bovine-derived products. Cryoport is providing the validated cryogenic logistics to deliver to ZenBio customers worldwide.